ADVFN - Advanced Financial Network.
HOME» NYSE » M » MDT Stock Price » MDT Stock News

Medtronic Share News

 Medtronic, Inc. Stock Price
MDT Stock Price
 Medtronic, Inc. Stock Chart
MDT Stock Chart
 Medtronic, Inc. Stock News
MDT Stock News
 Medtronic, Inc. Company Information
MDT Company Information
 Medtronic, Inc. Stock Trades
MDT Stock Trades

St Jude Defibrillator Lead Performed Worse Than Competitor Lead -Study

By Anjali Athavaley Of DOW JONES NEWSWIRES NEW YORK -(Dow Jones)- St. Jude Medical Inc.'s (STJ) Riata defibrillator leads performed significantly worse than Medtronic Inc.'s (MDT) Quattro leads, according to results from a multicenter study presented at a medical meeting Thursday. St. Jude stopped selling the Riata leads in 2010, but about 79,000 are still implanted in patients in the U.S. St. Jude said last year it was recalling them due to a tendency for the metal wires to wear through their silicone covering. Data in the study, presented at the Heart Rhythm Society meeting in Boston, was collected retrospectively from seven centers. Researchers evaluated the leads for all causes of failure, including cases where cables wore through their coating and electrical malfunctions. Riata, but not Riata ST, leads performed significantly worse than Quattro, according to the study. But follow-up for Riata ST was shorter than it was for Riata. The study also found that nearly a third of leads with exposed cables were malfunctioning. St. Jude said in a statement that the data is consistent with the company's findings that significant design changes implemented in the Riata ST leads resulted in improved performance compared to the Riata leads. In March, a study authored by Robert G. Hauser, a Minnesota cardiologist, tied a malfunction in Riata to at least 20 deaths. Dr. Hauser said the deaths alleged from Riata malfunctions were about nine times greater than Quattro. Last month, St. Jude said it was seeking a retraction of the study, published in the Heart Rhythm Journal. The company says Dr. Hauser undercounted deaths linked to Quattro. St. Jude shares were up 2.3% to $40.12 in recent trading. The stock is down 24% in the last year. -By Anjali Athavaley, Dow Jones Newswires; 212-416-4912; anjali.athavaley@dowjones.com

Stock News for Medtronic (MDT)
DateTimeHeadline
03/26/201509:16:52Lombard's Unique Stent-Graft Rapidly Penetrating Endovascular...
03/25/201517:04:25Amended Current Report Filing (8-k/a)
03/25/201516:00:00Medtronic Highlights New Data in JAMA Surgery Demonstrating Significant...
03/24/201506:33:37Medtronic Files 8K - Regulation FD
03/20/201518:43:04Statement of Changes in Beneficial Ownership (4)
03/20/201509:00:00Next Week In Biotech: Pediatric Safety Ad Comm, BIO Asia, Sinovac...
03/18/201508:33:32'New' Medtronic Significantly Undervalued After Merger With Covidien
03/17/201520:41:39Dividend Growth Checkup - Part II
03/17/201515:36:42Statement of Changes in Beneficial Ownership (4)
03/16/201517:39:12Why Edwards Lifesciences Sky-Rocketed Today
03/16/201511:00:26Medtronic Seeks Runners with Medical Technology for 2015 "Global...
03/16/201507:44:56Two-year data show Medtronic CoreValve TAVR patients do better...
03/15/201513:45:27Medtronic CoreValve® System Sustains Superior Survival Benefit...
03/14/201518:45:35Medtronic to Initiate Clinical Study of Drug-Filled Stent Following...
03/14/201515:00:22Medtronic CoreValve® Evolut(TM) R System Yields Exceptional...
03/12/201509:30:32Medtronic Initiates Pivotal Studies of Resolute Onyx(TM) Drug-Eluting...
03/09/201518:45:33Why Medtronic-Covidien Deal Will Lead To Strong 2015 Performance
03/03/201518:07:15NuVasive: Court Overturns $102 Million Award to Medtronic--Update
03/03/201517:44:58NuVasive: Court Overturns $102 Million Award to Medtronic
03/03/201516:00:43Medtronic EVP & CFO Gary Ellis to Speak at Barclays Healthcare...

Medtronic and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad